SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • August 19th, 2022 • Kymera Therapeutics, Inc. • Biological products, (no disgnostic substances) • New York
Contract Type FiledAugust 19th, 2022 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of August 18, 2022, by and between Kymera Therapeutics, Inc., a Delaware corporation (the “Company”), and each of the several purchasers identified on the signature page hereto (each, including its successors and assigns, a “Purchaser”).
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • August 19th, 2022 • Kymera Therapeutics, Inc. • Biological products, (no disgnostic substances)
Contract Type FiledAugust 19th, 2022 Company IndustryThis Agreement is made pursuant to the Securities Purchase Agreements, each dated as of the date hereof, between the Company and each Purchaser (collectively, the “Purchase Agreements”).